Supplementing with large doses of Q10 may help reduce pain and fatigue in people who suffer from fibromyalgia. An optimal treatment of the disease may even require focusing on underlying causes.
Omega-3 fatty acids belong to a group of polyunsaturated fatty acids. Their "omega-3" name indicates that they have a double bond at the third carbon atom in the middle carbon chain. Omega-3 fatty acids provide energy and constitute an important element in all cell membranes and various biochemical processes. The type known as ALA (alpha-linoleic acid) is essential, as the human body is unable to produce it. We depend on a dietary supply of this fatty acid. By means of enzymes, ALA is converted to EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) and finally into some hormone-like substances named prostaglandins (E3).
Besides causing pain in joints, osteoarthritis may lead to neck pain, headaches, back pain, tennis elbow, and other symptoms, many of which we normally wouldn't associate with osteoarthritis. It is therefore vital to address the underlying cause. An increasing number of studies show that glucosamine can halt the progression of osteoarthritis and, subsequently, slam the brakes on the accompanying pain. It is, however, important to choose glucosamine in drug form with the type of glucosamine called glucosamine sulfate in order to obtain the desired effect.
We all get exposed to mercury, a neurotoxin that is found to a great extent in nature and in our environment. According to an EU report, mercury is a large economic burden to society because of the costs related to lowered IQ levels. For that reason alone, we should aim to limit our exposure to mercury and also take a closer look at how selenium protects against the harmful heavy metal – provided our selenium levels are adequately high.
People who train regularly have 25% less muscle and joint pain on average in old age than those who are less active, according to a study that was published in the science journal Arthritis Research & Therapy.
For a period of 14 years, a team of scientists from Stanford University followed a group of runners together with a control group and compared pain levels in the two groups. A total of 866 people took part in the study: 492 were members of Runners' Association and 374 served as controls.